Alkermes announces decision to make significant investment to further modernise its Athlone manufacturing facility.
Alkermes is making new investments at its Athlone site to strengthen future growth and competitiveness. The investment is bolstered by Alexion Pharmaceuticals, Inc.’s recent purchase of two Alkermes buildings in Athlone.
Alkermes has shown its commitment to in Ireland and will invest €20m in the Athlone site over three years to enhance its R&D and manufacturing facility.
“The business-friendly government, accommodating community, and outstanding team of people at the Athlone site provide tremendous support to Alkermes in Ireland,” said Declan O’Connor, general manager of Alkermes’ manufacturing facility in Athlone. “We look forward to enhancing our presence in Athlone, continuing to make a positive contribution in Ireland and are delighted to have been able to facilitate the entry of a new pharmaceutical company to the country.”